Article

Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus…

Research square · 2021 · Valeria Cagno, author Chiara Medaglia, author Andreas Cerny, author Thomas Cerny, author Arnaud Charles-Antoine Zwygart, author Erich Cerny, author Caroline Tapparel, author

Key facts

Title Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro
First author Valeria Cagno, author Chiara Medaglia, author Andreas Cerny, author Thomas Cerny, author Arnaud Charles-Antoine Zwygart, author Erich Cerny, author Caroline Tapparel, author
Journal Research square
Published Feb 17, 2021
DOI 10.21203/rs.3.rs-134789/v1
Devices mentioned K042152, K940422, K982100
Product codes mentioned CFN, DFZ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature